Pharmacodynamic target attainment of six β‐lactams and two fluoroquinolones against Pseudomonas aeruginosa, Acinetobacter baumannii, Escherichia coli, and …

CA DeRyke, JL Kuti, DP Nicolau - … : The Journal of Human …, 2007 - Wiley Online Library
… to be a challenge for clinicians. Reports of increased … Each center’s laboratory identified
the species by means of … interscience conference on antimicrobial agents and chemotherapy, …

[HTML][HTML] The demand for new antibiotics: antimicrobial peptides, nanoparticles, and combinatorial therapies as future strategies in antibacterial agent design

A León-Buitimea, CR Garza-Cárdenas… - Frontiers in …, 2020 - frontiersin.org
problems, since it has a significant impact on the economy worldwide. Since therapeutic
options to treat infections … well as the identification of the most promising antimicrobial agents for …

Insights into Acinetobacter baumannii: A Review of Microbiological, Virulence, and Resistance Traits in a Threatening Nosocomial Pathogen

C Ayoub Moubareck, D Hammoudi Halat - Antibiotics, 2020 - mdpi.com
baumannii, challenging and diverse resistance mechanisms in … The identification of
Acinetobacter to the species level … to antimicrobial agents through enzymatic modification of …

Challenging antimicrobial susceptibility and evolution of resistance (OXA-681) during treatment of a long-term nosocomial infection caused by a Pseudomonas …

J Arca-Suárez, P Fraile-Ribot… - Antimicrobial agents …, 2019 - Am Soc Microbiol
… the MBL VIM-20, resulting in a challenging MBL/ES-OXA MDR element that … identified in
the early isolate of this work, which is a hallmark of strains recovered from long-term infections

Emerging gram-negative antibiotic resistance: daunting challenges, declining sensitivities, and dire consequences

RE Siegel - Respiratory care, 2008 - rc.rcjournal.com
… as Pseudomonas aeruginosa and Acinetobacter baumannii employ a … Challenges in
identifying new antimicrobial agents effective for treating infections with Acinetobacter baumannii

… cefiderocol against high-risk clones of multidrug-resistant Enterobacterales, Acinetobacter baumannii, Pseudomonas aeruginosa and Stenotrophomonas maltophilia

M Delgado-Valverde, MC Conejo… - … of Antimicrobial …, 2020 - academic.oup.com
Infections caused by these bacteria are very difficult to treat since strains are resistant to all
… following ranges of antimicrobial agents (mg/L) for Enterobacterales, P. aeruginosa and A. …

Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era?

ME Falagas, IA Bliziotis - International journal of antimicrobial agents, 2007 - Elsevier
problems they pose. The fears for the dawn of a post-… Pseudomonas aeruginosa,
Acinetobacter baumannii and … (ie identification of appropriate antibiotic therapy for patients with …

Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options

M Kempf, JM Rolain - International journal of antimicrobial agents, 2012 - Elsevier
… is the class D oxacillinase, which is represented by three main gene clusters identified either
in … One of the main problems with A. baumannii infections is the definition of infection itself. …

Challenge in the discovery of new drugs: antimicrobial peptides against WHO-list of critical and high-priority bacteria

CA Roque-Borda, PB da Silva, MC Rodrigues… - Pharmaceutics, 2021 - mdpi.com
drugs, such as ciprofloxacin, were used to treat infectious … as CarO proteins, would be the
main way to identify their … 1B in Enterobacteriaceae and Pseudomonas aeruginosa and the …

Treatment of Acinetobacter infections

A Michalopoulos, ME Falagas - Expert opinion on …, 2010 - Taylor & Francis
… : All potential antimicrobial agents that are available for the treatment of … baumannii or
Pseudomonas aeruginosa. … Perhaps the biggest future challenge in achieving this goal concerns …